Activity of selpercatinib in RET fusion-positive cancers confirmed
Crossref DOI link: https://doi.org/10.1038/s41571-022-00694-2
Published Online: 2022-10-07
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Romero, Diana
Text and Data Mining valid from 2022-10-07
Version of Record valid from 2022-10-07
Article History
First Online: 7 October 2022